Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Hansmann

Showing results (221-230 of 240) with videos related to

Pageof 24
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 15, 2002
Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphomaM J Rummel, K U Chow, T Karakas, et al.
Onkologie|July 7, 2001
Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicineE Weidmann, S Boehrer, K U Chow, et al.
Blood|August 29, 2000
European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytesI Anagnostopoulos, M L Hansmann, K Franssila, et al.
American Journal of Hematology|January 5, 2002
Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphomaJ I Martin-Subero, R Siebert, L Harder, et al.
Leukemia|August 7, 2009
Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphomaS Eckerle, V Brune, C Döring, et al.
Leukemia|December 15, 2015
Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphomaS Hartmann, B Schuhmacher, T Rausch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2016
Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHLK Koch, E Hoster, M Ziepert, et al.
Leukemia|August 20, 2016
Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphomaK D Wurster, F Hummel, J Richter, et al.
The Journal of Pathology|June 2, 2006
Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomasS Tedoldi, J C Paterson, J Cordell, et al.
The Journal of Pathology|October 16, 2007
Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphomaS Tedoldi, A Mottok, J Ying, et al.
Pageof 24

Showing results (221-230 of 240) with videos related to

Sort By:
Pageof 24
European Journal of Cancer (Oxford, England : 1990)|August 15, 2002
Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphomaM J Rummel, K U Chow, T Karakas, et al.
Onkologie|July 7, 2001
Treatment of aggressive, or progressing indolent peripheral T- and NK-cell neoplasias by combination of fludarabine, cyclophosphamide and doxorubicineE Weidmann, S Boehrer, K U Chow, et al.
Blood|August 29, 2000
European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytesI Anagnostopoulos, M L Hansmann, K Franssila, et al.
American Journal of Hematology|January 5, 2002
Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphomaJ I Martin-Subero, R Siebert, L Harder, et al.
Leukemia|August 7, 2009
Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphomaS Eckerle, V Brune, C Döring, et al.
Leukemia|December 15, 2015
Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphomaS Hartmann, B Schuhmacher, T Rausch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2016
Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHLK Koch, E Hoster, M Ziepert, et al.
Leukemia|August 20, 2016
Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphomaK D Wurster, F Hummel, J Richter, et al.
The Journal of Pathology|June 2, 2006
Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomasS Tedoldi, J C Paterson, J Cordell, et al.
The Journal of Pathology|October 16, 2007
Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphomaS Tedoldi, A Mottok, J Ying, et al.
Pageof 24